9
Feb
2021
A major milestone in the medical cannabinoid patent market has been passed Read more
8
Feb
2021
Recent decision to award Eli Lilly a preliminary injunction and damages in case against a generic company demonstrates an increasingly pro-rights holder approach on the part of a key French court Read more
6
Feb
2021
Continued criticism of biopharma patent owners fails to acknowledge that manufacturing and supply complexities are the real obstacles to mass inoculation around the world Read more
4
Feb
2021
Recent caselaw has raised serious doubts over the enforceability of US genus claims, leaving life sciences innovators in a quandary Read more
